Ryan Holstead to Melanoma
This is a "connection" page, showing publications Ryan Holstead has written about Melanoma.
Connection Strength
0.956
-
Holstead RG, Kartolo BA, Hopman WM, Baetz TD. Impact of the development of immune related adverse events in metastatic melanoma treated with PD -1 inhibitors. Melanoma Res. 2021 06 01; 31(3):258-263.
Score: 0.554
-
Kartolo A, Deluce J, Holstead R, Hopman W, Lenehan J, Baetz T. Impact of Baseline Corticosteroids on Immunotherapy Efficacy in Patients With Advanced Melanoma. J Immunother. 2021 05 01; 44(4):167-174.
Score: 0.138
-
Kartolo A, Holstead R, Hopman W, Baetz T. Prognosticating role of serum eosinophils on immunotherapy efficacy in patients with advanced melanoma. Immunotherapy. 2021 02; 13(3):217-225.
Score: 0.134
-
Kartolo A, Holstead R, Khalid S, Emack J, Hopman W, Robinson A, Baetz T. Serum neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in prognosticating immunotherapy efficacy. Immunotherapy. 2020 08; 12(11):785-798.
Score: 0.130